CoChat

A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression

Open access

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Abstract

Background Ketamine has rapid-acting antidepressant effects but is associated with psychotomimetic and other adverse effects. A 7-chlorokynurenic acid is a potent and specific glycine site N-methyl-d-aspartate receptor antagonist but crosses the blood-brain barrier inefficiently. Its prodrug, L-4-chlorokynurenine (4-Cl-KYN), exerts acute and sustained antidepressant-like effects in rodents and has no reported psychotomimetic effects in either rodents or healthy volunteers. This study examined whether 4-Cl-KYN has rapid antidepressant effects in individuals with treatment-resistant depression. Methods After a 2-week drug-free period, 19 participants with treatment-resistant depression were randomized to receive daily oral doses of 4-Cl-KYN monotherapy (1080 mg/d for 7 days, then 1440 mg/d for 7 days) or placebo for 14 days in a randomized, placebo-controlled, double-blind, crossover manner. The primary outcome measure was the Hamilton Depression Rating Scale score, assessed at several time points over a 2-week period; secondary outcome measures included additional rating scale scores. Pharmacokinetic measures of 7-chlorokynurenic acid and 4-Cl-KYN and pharmacodynamic assessments were obtained longitudinally and included 1H-magnetic resonance spectroscopy brain glutamate levels, resting-state functional magnetic resonance imaging, and plasma and cerebrospinal fluid measures of kynurenine metabolites and neurotrophic factors. Results Linear mixed models detected no treatment eff…

Overview

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyaa025

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. Food and Drug Administration, 1997, Guidance document: dissolution testing of immediate release solid oral dosage forms (No. 97D-0331)

Cited by

See all 67

Metadata

Authors
Park, L. T., Kadriu, B., Gould, T. D., Zanos, P., Greenstein, D., Evans, J. W., Yuan, P., Farmer, C. A., Oppenheimer, M., George, J. M., Adeojo, L. W., Snodgrass, H. R., Smith, M. A., Henter, I. D., Machado-Vieira, R., Mannes, A. J., & Zarate, C. A.
Affiliations
  • National Institutes of Health (US)
  • University of Maryland, Baltimore (US)
  • VistaGen Therapeutics (United States) (US)
  • Augusta University (US)
  • Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Science Center, Houston, TX
Corresponding author
Park, Lawrence T
Venue
International Journal of Neuropsychopharmacology
Published
2020-03-31
Volume
23
Issue
7
Pages
417-425
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W3014355680
Cited by
63
References
47
Citations by year
2026: 3 · 2025: 7 · 2024: 11 · 2023: 6 · 2022: 14 · 2021: 13 · 2020: 9
FWCI
6.30
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Mental Health (ZIAMH002857, NCT02484456)
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
treatment-resistant depression, 7-chlorokynurenic acid, prodrugs, antidepressant efficacy, psychotomimetic effects, kynurenine metabolites, brain glutamate, neurotrophic factors, drug safety and tolerability
MeSH terms
Adolescent, Adult, Aged, Animals, Antidepressive Agents, Brain, Brain Chemistry, Double-Blind Method, Female, Glycine, Humans, Kynurenine, Magnetic Resonance Imaging, Male, Middle Aged, Prodrugs, Psychiatric Status Rating Scales, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Cross-Over Studies, Mice, Young Adult, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression. https://app.cochat.ai/papers/10.1093/ijnp/pyaa025
The paper
Park, L. T., Kadriu, B., Gould, T. D., Zanos, P., Greenstein, D., Evans, J. W., Yuan, P., Farmer, C. A., Oppenheimer, M., George, J. M., Adeojo, L. W., Snodgrass, H. R., Smith, M. A., Henter, I. D., Machado-Vieira, R., Mannes, A. J., & Zarate, C. A. (2020). A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaa025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.